Production and distribution of in vitro diagnostic reagents and research products for haemostasis and thrombosis.

The company

Specialising in the field of haemostasis, Cryopep offers the medical biology laboratories a new alternative to the traditional lyophilised reagents, an innovative range of ready to use reagents. The company is based in Montpellier (France), in the heart of a business park and benefits from this dynamic to perform all its activities. Since it was founded in 2008 the development of the company has accelerated and Cryopep’s activities now cover France and some European countries. The rapid growth this company is experiencing is due mainly to the marketing of frozen reagents and plasmas for diagnostic and research applications. The company is compliant with the regulations in force (CE and FDA marking, standard ISO 13485). Apart from its know-how and its innovation, the company Cryopep is a key partner in the investigation of the diseases of haemostasis, thrombosis and autoimmunity.


The C.E.O., Mr Bénattar Norbert, has worked in the field of haemostasis since 1987. He was initially a employee of the company Diagnostica Stago, then of the company Biogenic/Chromogenix from 1987 to 2000.
ANVAR winner in 2000 of the National Contest for Assistance in the Creation of Innovative Technology Companies, he founded the company Biopep in 2000, a haemostasis production company which was sold to the Horiba ABX Group in 2003. He occupied the position of marketing and sales manager until 2008. In 2008 he founded the company Cryopep, which he has managed ever since.

Our customers

Comprising mainly hospital centres (hospital centres and university hospital centres), pharmaceutical industries, highly specialised clinical biology laboratories and research laboratories, they use our diagnostic tests and our research reagents and have put their trust in our reagents continuously since their launch onto the French, then the European market, thus bearing witness to their permanent satisfaction. A very large number of customers (over 800 throughout the world) work with these reagents, particularly in Europe, U.S.A. and Canada. The research reagents are used essentially by university hospital research centres, medical research institutes and the pharmaceutical industry.